Steris | STE - Ordinary Share Capital


Steris reported $98.07M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
3M USD 515.72M 5.84M Jun/2026
Accuray USD 100K 1000 Sep/2024
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
CONMED USD 29.99M 157K Jun/2026
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 377.4M 8.5M Jun/2026
Ecolab USD 281.4M 1.02M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Fortive USD 302.6M 3M Jun/2026
Getinge SEK 272.37M 136.37M Jun/2026
Globus Medical USD 135.67M 611K Mar/2026
Haemonetics USD 46.83M 82K Dec/2025
Idexx Laboratories USD 79.24M 611K Mar/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Olympus JPY 1.1B 35.42K Mar/2026
Orthofix International USD 39.83M 315K Dec/2025
Owens Minor USD 76.39M 911K Dec/2025
ResMed USD 190.83M 44.86M Mar/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026